Acuta Capital Partners’s Forte Biosciences FBRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-18,469	Closed	-$143K	–	31
2025 Q1	$143K	Buy	18,469 +330	+2%	+$2.56K	0.17%	31
2024 Q4	$412K	Buy	+18,139	New	+$412K	0.41%	35
2017 Q4	–	Sell	-670	Closed	-$3.13M	–	42
2017 Q3	$3.13M	Buy	+670	New	+$3.13M	0.56%	23